Health

SHINE and Sumitomo Corporation of Americas Announce Partnership to Expand Medical Isotope and Fusion Technology Distribution in Asian Markets
MYndspan Launches Crowdfunding Campaign to Expand Access to Preventive Brain Health Technology
MicuRx: 15 Clinical and Preclinical Research Studies to be Presented at ESCMID Global 2025
Xeltis successfully passes evaluation phase for €10million investment from European Innovation Council
LOG Pharma Primary Packaging Ensures Maximum Confidence for Drug Manufacturers with Bottle and Closure Solutions
Sectra's fully managed AI offering extended to include pathology following new Amplifier partner agreement
Johnson & Johnson highlights new data that showcase the strength of nipocalimab, demonstrating long-term sustained disease control in adults living with generalized myasthenia gravis (gMG)
Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDMâ„¢ Platform and its Liquid Biopsy Capabilities
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
How a surgeon tried to avoid justice for years after stabbing colleague
Synthego and Vita Therapeutics Announce Strategic Licensing Agreement for hfCas12Max CRISPR Nuclease
National Security Commission on Emerging Biotechnology Urges Swift Action to Protect U.S. National Security
Vohra Wound Physicians Responds to Department of Justice Lawsuit
Evolutionary: World's Largest Class Single Crystal Diamond Radiation Detector
The English neighbourhood that could hold the secret to fixing the NHS
The Inner Circle acknowledges, Lloyd Costello, MD as a Pinnacle Lifetime Member
The Inner Circle acknowledges, Cha-Mei Tang as a Pinnacle Professional Member Inner Circle of Excellence
Regulatory T-cells (Tregs) Market to Observe Significant Growth by 2034 Owing to the Development in 12+ Indications with Severe and Refractory Patients as the Treatment Addressable Population | DelveInsight
IMA Medical Group Welcomes Dr. Siren Chudgar as Chief Medical Officer
NeuroSense Therapeutics Reports Year End 2024 Financial Results and Provides Business Updates